The way to build bridges instead of walls is still long, but I am happy to have got European Union funding for this project. Africlinique project aims to increase the capacity to oversight clinical trials addressing deadly diseases in Central African countries (specifically Republic of the Congo, Democratic Republic of the Congo, Cameroon and Gabon). This achievement was made possible thanks to the exciting proactiveness and invaluable collaboration of a Central African team lead by Prof. Francine Ntoumi, already coordinator of Central Africa Network on Tuberculosis, HIV/AIDS and Malaria (CANTAM).

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Ebola outbreak in Republic Democratic of the Congo: switching from MEURI (Monitored Emergency Use of Unregistered and Investigational Interventions) to a RCT (Randomized Clinical Trial) for 4 experimental medications in the treatment of Ebola Virus Disease

An international research team has begun patient enrollment in a clinical trial testing multiple investigational Ebola therapies in the Democratic Republic of the Congo (DRC). The randomized, controlled trial is

Read More

AfriEthique

A European-African partnership aimed at improving the ethics and regulatory capacity of clinical research in Central African countries has successfully proposed its project (AfriHetique) to the European Commission (EDCTP). The partnership

Read More

ImproViTB

With 1 million new cases and 200,000 children dead each year, Tuberculosis (TB) is now the leading cause of death from infectious diseases for children of all ages globally (UNICEF).

Read More